|
LRRFIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.17665901863984E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.69630975932478E-12 |
| Stage1-vs-Stage2 |
4.668400E-01 |
| Stage1-vs-Stage3 |
2.438800E-01 |
| Stage1-vs-Stage4 |
2.556800E-01 |
| Stage2-vs-Stage3 |
9.000600E-01 |
| Stage2-vs-Stage4 |
7.778000E-01 |
| Stage3-vs-Stage4 |
8.420600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.81540038346873E-10 |
| Normal-vs-Asian |
2.93419999408684E-09 |
| Caucasian-vs-AfricanAmerican |
9.119800E-01 |
| Caucasian-vs-Asian |
2.864000E-01 |
| AfricanAmerican-vs-Asian |
5.895000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.500800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.606190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.867800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.213800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.559200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.700600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.072400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.854200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.355200E-01 |
| Classical-VS-Follicular |
7.958600E-01 |
| Classical-VS-Other |
4.623400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.264400E-01 |
| Tall-VS-Other |
8.917200E-01 |
| Tall-VS-Normal |
3.07531777821168E-12 |
| Follicular-VS-Other |
5.718400E-01 |
| Follicular-VS-Normal |
1.75981451633334E-12 |
| Other-VS-Normal |
1.80234999999085E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
8.49320613838245E-14 |
| N0-vs-N1 |
7.447000E-01 |
|
|
